Sermorelin FAQ: insomnia, night timing and names

Can Sermorelin cause insomnia?

The supplied studies give no measured rate of Sermorelin-related insomnia. Community accounts describe mixed sleep experiences, including disturbed nights; those are anecdotal accounts, not clinical evidence establishing a cause. The GHRH sleep experiment in healthy men found more slow-wave sleep, while another experiment showed that timing changed the effect.

Dismissing someone’s sleeplessness on either basis seems presumptuous to me. The sleep page follows the experiments more closely. An individual symptom needs assessment by a licensed clinician.

Why take Sermorelin at night?

That search question comes from the connection between deep sleep and the largest daily GH pulse. Bedtime was used in the pediatric growth trial, and GHRH’s sleep-endocrine effects depended on administration time. These facts explain the research interest in the clock.

A study’s chosen time describes its protocol. The evidence here supplies no best hour for an individual prescription.

Somatorelin searches and the compound name

If “somatorelin” led to this page, the subject here is Sermorelin acetate, the synthetic GHRH(1-29) fragment. The review of GHRH and its analogues supplies the pharmacological context. A similar-looking search term is too little information to identify a medicine or to transfer findings between compounds.

Does Sermorelin raise testosterone?

The study in healthy older men measured GH and IGF-1 responses. It establishes no direct testosterone effect from Sermorelin. GH and IGF-1 are the hormonal endpoints that support the claim on this site; testosterone would need its own evidence.

Does Sermorelin help weight loss or muscle growth?

The direct studies here establish neither an adult weight-loss treatment nor a muscle-building result. The often-repeated reduction in percent body fat of 7.4% came from a tesamorelin trial. I’d give that number its proper drug name every time: it is appealing enough to be repeated carelessly.

The research page also explains the cognition result from that trial and the separate animal work involving ipamorelin.

What Sermorelin side effects appeared in studies?

Mild injection-site irritation appeared in the pediatric comparison study. Other work recorded small short-term changes in additional pituitary hormones. Related analogs had their own findings, including glucose-tolerance impairment in elderly subjects and transient blood-lipid elevation.

The safety page distinguishes those preparations and discusses the unresolved long-term adult questions. It would be misleading to turn this mixed collection into one Sermorelin adverse-event rate.

Was Sermorelin FDA-approved?

Yes. The manufactured prescription drug had FDA approval for growth-hormone deficiency and short stature in children and was used diagnostically. It left the US market in 2008 for commercial reasons, rather than a known safety or effectiveness failure. The pediatric review and post-discontinuation clinical review describe that history and its consequences.

Today compounded sermorelin is prepared for an individual patient after a licensed provider’s assessment and prescription; some patients do not qualify. Compounded medications do not have FDA approval. FDA treats sermorelin as Category 1 under its interim Section 503A compounding policy, which is a compounding-policy category.

Is Sermorelin banned in sport?

Growth-hormone secretagogues, including GHRH analogs, are prohibited in sport. The review of GHRH-analog detection describes the analytical methods developed for anti-doping work. The former medical approval does not remove that sporting restriction.